
    
      After the screening visit, subjects will be randomized to come for two overnight visits.
      Study A- the subjects will be on the closed loop device with Novolog rapid acting insulin. In
      Study B- in addition to insulin the subjects will take a one time sub cutaneous injection of
      1.2 mg of Victoza before dinner on Day 1. Both visits will last for approximately 30 hours
      and the subjects will be managed by the closed loop device for approximately 25 hours.
    
  